Graft artery stenosis is one of the main causes of hypertension in renal transplant recipients. We present a rare case of severe common iliac artery stenosis, proximal to the graft artery, that was the cause of accelerated hypertension and claudication in a male renal transplant
Introduction
Hypertension is a significant cause of graft dysfunction and failure in renal transplant recipients. The usual factors which may cause hypertension are: acute and chronic rejection, cyclosporine toxicity, native kidney hypertension, urinary obstruction and renal artery stenosis. In these patients it is necessary to identify the exact cause of hypertension, as appropriate treatment may prevent graft failure. 1, 2 In this report we present a renal transplant recipient with iliac artery disease, complicated by renovascular hypertension and claudication, which was managed by angioplasty combined with a Palmaz stent implantation.
Case report
A 44-year-old male with end-stage renal failure secondary to chronic glomerulonephritis, started maintenance haemodialysis in 1985. In January 1994 he underwent subtotal parathyroidectomy for uncontrolled secondary hyperparathyroidism. At that time, he had extended atherosclerotic vascular disease and mild hypertension.
In June 1995, he received a cadaveric renal transplant. Graft function was excellent (serum creatinine 115 mol/L) and the post-transplant course was uneventful. He was on triple immunosuppressive treatment (prednizolone, azathioprine, cyclosporine) and on anti-hypertensive treatment (nitrendipine 60 mg, furosemide 40 mg) with adequate control of his blood pressure (140/80 mm Hg).
In September 1996, he presented accelerated hypertension (BP 210/125 mm Hg) and severe right leg claudication. On physical examination there were bruits over the renal graft. The laboratory values were as follows: serum creatinine 115 mol/L, urea 6.8 mmol/L, haemoglobin 13.1 gr/dl, haematocrit 44%, sodium 140 mmol/L, potassium 5.1 mmol/L, calcium 2.4 mmol/L, and cyclosporine within therapeutic levels. Urinalysis revealed 0-1 red cells/field, 0-2 leucocytes/field and no proteinuria. Fundoscopy revealed haemorrhages and cotton wool spots, but not papilledema. Furthermore, a coloured Doppler ultrasound examination of the graft artery and a scintiscan (99 mTc-DTPA) could not detect any essential abnormality. However, the angiographic evaluation ( Figure 1 ) revealed severe stenosis of the right common iliac artery proximal to the transplant artery. The patient's medications were modified as follows: nifedipine 60 mg, atenolol 100 mg, terazosin 15 mg, furosemide 80 mg daily, and his immunosuppressive drugs were prednizolone 7.5 mg, azathioprine 100 mg and cyclosporine 300 mg daily. Despite the above regime, his blood pressure was inadequately controlled and claudication became worse. Under these circumstances, we decided to manage the iliac artery stenosis with percutaneous balloon angioplasty, followed by a Palmaz stent implantation (Figure 1) .
After the successful procedure of stent implantation, blood pressure was controlled by 40 mg nifedipine daily, and claudication improved. A mild increase of serum creatinine (159 mol/L) was observed after the procedure, although action was taken to hydrate the patient before angioplasty, but fell in 2 weeks back to pre-angioplasty levels (106 mol/L). During the following 10 months antihypertensive medications were gradually tapered and finally stopped. The graft function remains well preserved and the patient reports disappearance of claudication.
Discussion
Many factors may cause hypertension in renal transplant recipients. However, renal artery stenosis may cause drug-resistant hypertension and therefore it is a major factor of graft failure. [1] [2] [3] In renal transplant recipients vascular hypertension may be due, not only to stenosis of the renal artery, but also to the arteries proximal to the graft artery, which is an unusual finding. 4, 5 In our case it was known that the patient was atherosclerotic, therefore the concomitant claudication, combined with the deterioration of blood pressure led to the angiographic evaluation, not only in the renal artery, but also in the arteries proximal to the renal graft, demonstrating a highly significant stenosis in the right common iliac artery.
Current concepts in the treatment of vascular stenosis include surgical revasculization, percutaneous transluminal balloon angioplasty (PTA) and dilatation followed by stent implantation. Surgical intervention is usually recommended for stenosis, either inaccessible to PTA and stent implantation, or after unsuccessful angioplasty. PTA is widely established for treating renal artery stenosis. However, many recent studies have shown that it is less beneficial in patients with atherosclerotic stenosis. 1, 2 The use of vascular stents has been accepted as a possible adjunct to PTA in arterial disease of iliac, femoral, popliteal, carotid and coronary vessels. Angioplasty followed by implantation of a stent, provides a degree of protection against early occlusion and late restenosis. [1] [2] [3] Recently, a case of a renal transplant recipient who developed severe hypertension and graft failure due to atherosclerotic stenosis of the common and external artery has been reported. In that patient, hypertension and graft dysfunction were cured after the implantation of three Palmaz stents. 5 The major symptoms of our patient were severe claudication and accelerated hypertension with stable renal function (serum creatinne 115 mol/L). These findings led us to suspect vascular disease proximal to the graft artery. Angiographic evalution confirmed our suspicions. By early implantation of a stent, claudication and hypertension were cured and graft failure was prevented. Anti-hypertensive medications were tapered and stopped, while before stenting the regime included four different classes of drugs with only moderate success. Serum creatinine showed a transient increase (159 mol/L) after the angioplasty procedure, but fell gradually to the preangioplasty levels (106 mol/L). At the same time cyclosporine dose and plasma levels remained unchanged.
In conclusion, stent implantation in the iliac artery of renal transplant recipients with atherosclerotic vascular disease, seems to be safe and effective treatment for hypertension, claudication and preservation of graft function. However, the longterm efficacy of stent placement in these patients needs further studies with more subjects and longer follow-up period.
